Search Videos and More
Therapies for BPD-Associated Pulmonary Hypertension – What Do We Know Now?
Dr. Kevin Engelhardt presented on therapy options for BPD-associated pulmonary hypertension.Renowned Fetal Imaging Team Helps Improve Outcomes Among Babies with Congenital Defects
Thanks to the sophisticated technology and skilled fetal imaging specialists at Phoenix Children’s, more high-risk infants have a chance to live long, healthy lives.Phoenix Children's Research Institute Study Identifies FOXF1 Enhancers Involved in Rare Lung Disease
The FOXF1 protein is critically important in pulmonary vascular development, specifically responsible for the extension and branching of airways and blood vessels in the developing lung.Emerging Therapies for Prevention and Treatment of BPD
Dr. Vlad Kalinichenko considered the use of novel pharmacologic treatments that may prevent BPD and/or more effectively treat the manifestations of BPD.2023 Perspectives in Bronchopulmonary Dysplasia – Pharmacology of BPD
In September 2023, Phoenix Children’s Center for Fetal and Neonatal Care hosted its annual Bronchopulmonary Dysplasia (BPD) Conference.Prenatal Detection of Congenital Heart Disease: Recent Experience Across the State of Arizona
This was a retrospective chart review using the Society of Thoracic Surgeons and Phoenix Children's Fetal Cardiology databases.Clubfoot: Diagnosis, Treatment and Prognosis
For babies with clubfoot, the prognosis has never been better. Jessica Burns, MD, orthopedic surgeon, discusses prenatal diagnosis and misconceptions about treatment.Perinatal Palliative Care Team Offers Expectant Families an Expert, Earnest Layer of Guidance and Support
After a recent expansion of its pediatric palliative care program, Phoenix Children’s now offers customized, coordinated care to expectant parents who learn their baby has a serious congenital anomaly.Phoenix Children’s Researcher Awarded $3 Million Grant to Develop New Therapy for Lung Diseases in Premature Babies
An internationally renowned research scientist at the Phoenix Children’s Research Institute at the University of Arizona College of Medicine – Phoenix has been awarded a multimillion-dollar grant from the National Institutes of Health (NIH) to develop new treatment methods for lung disease in premature infants.Congenital Heart Disease: Helping Parents and Providers
Congenital heart disease is a common birth defect. Ericka Scheller McLaughlin, DO, pediatric and fetal cardiologist, discusses what parents can expect and how Phoenix Children’s can help.BPD: Progress Through Teamwork and the National BPD Collaborative
Bronchopulmonary dysplasia (BPD) is the most common respiratory complication of prematurity, affecting an estimated 10,000 to 15,000 babies in the U.S. annually - about 33 percent of babies born with a birthweight of less than 1,000 grams.Comprehensive Care for Congenital Heart Conditions
Given that congenital heart disease is the most prevalent type of birth defect in the U.S., it’s no surprise that roughly two-thirds of referrals to the Center for Fetal and Neonatal Care are for potential cardiovascular malformations.